Executive Summary
Join NIH leadership, and MedTech innovators at this premier annual showcase of breakthrough neurotechnology innovations ready for commercialization. The Blueprint MedTech program has created a unique ecosystem that de-risks early-stage MedTech investments through strategic NIH backing and proven translational pathways.
Key Value Propositions:
- Direct access to vetted, NIH-funded innovations across the full development pipeline from early feasibility to clinical translation
- Demonstrated ROI metrics and quantified success rates that validate investment opportunities
- Exclusive networking with NIH Institute leadership, successful innovator teams, and strategic industry partners
- Live demonstrations of cutting-edge neurotech solutions addressing major market needs
Investment-Ready Showcases:
- Success story panels featuring BPMT-funded teams with proven commercialization trajectories
- NeuroQuantum innovations representing the next frontier of neurological treatment and diagnosis
- Assistive and restorative MedTech addressing large, patient populations
- Patient-centered solutions with validated clinical need and market fit
Strategic Networking Opportunities: Interactive exhibitions and dedicated networking sessions designed to facilitate concrete collaboration discussions and strategic partnerships with innovators who have government validation and infrastructure support.
Keynote: “The Future of MedTech/ Innovation” 0 – 45 minutes
Riki Banerjee, PhD, Tangible Neurotech LLC
Panel and Discussion: “Neurotech Solutions: Meeting Patients Where They Are” 45 – 2:11
Moderator: C. Rory Goodwin, MD, PhD, Duke Department of Neurosurgery, Director Duke Center for Brain and Spine Metastasis
Panelists:
- Steven Schachter, MD, Mass General Research Institute, Chief Academic Officer for Cimit, Professor of Neurology at Harvard Medical School
- Allan Belzberg, MD, FRCSC, Neurosurgeon Johns Hopkins School of Medicine, George Heuer Professor of Neurosurgery, Director of Peripheral Nerve Surgery
- Henry Brem, MD, Neurosurgeon Johns Hopkins School of Medicine, Harvey-Cushing Professor of Neurosurgery and former Neurosurgeon-in-Chief Johns Hopkins University
- Sri Sarma, PhD, Professor Biomedical Engineering, Vice Dean graduate education Whiting School of Engineering, founder Neuromedical Control Systems Lab
- Rina Dirickson, Computational Neuroscience & Biophysics at The Johns Hopkins University, Mayo Clinic SURF 2025: patient perspective
Program Overview & Impact Metrics 2:12 – 2:47
- Paolo Bonato, PhD, Director of Motion Analysis Laboratory at Spaulding, Associate Professor, Harvard Medical School
- Youseph Yazdi, PhD, Executive Director, Center for Bioengineering Innovation and Design, Associate Professor Biomedical Engineering, Whiting School of Engineering, Johns Hopkins School of Medicine
Success Stories & Panel Discussion “The Blueprint MedTech Innovator Journey” 2:48 – 3: 40
Moderators:
- Santosh Venkatesha, MBA, Director Innovation and Admin Core, Johns Hopkins NeuroTech Harbor
- Evaristus Nwulia, MD, MHS Co-founder and Chief Scientific Officer Evon Medics, Professor of Neuroscience Howard University
- NeuroTech Innovator Presentations
Discussion: “NeuroQuantum: How clinical needs, challenges and forecasts dictate the direction of Neuro Innovation” 3:41 – 4:32
Panelists:
- Bob Storey Managing Partner The LaunchPort
- Ralph Etienne-Cummings, PhD, Professor of Electrical and Computer Engineering Johns Hopkins University
- Lara Jehi, MD, Chief Innovation Officer and Professor Neurology Cleveland Clinic and epilepsy specialist
- Wolfgang Losert, Professor of Physics, University of Maryland
Success Stories & Panel Discussion “Assistive and Restorative MedTech Advances” 4:33 to end
Moderator: Henry Brem, MD, Neurosurgeon Johns Hopkins School of Medicine, Harvey-Cushing Professor of Neurosurgery and former Neurosurgeon-in-Chief Johns Hopkins University
Panelists:
- Paolo Bonato, PhD, Director of Motion Analysis Laboratory at Spaulding, Associate Professor, Harvard Medical School
- Nitish Thakor, PhD, Professor, Johns Hopkins Biomedical Engineering Whiting School of Engineering and Neurology at Johns Hopkins School of Medicine
- Rahul Kaliki, PhD, CEO IBT, Adjunct Associate Professor Biomedical Engineering, Johns Hopkins University
